Dendritics

Dendritics is a French biotechnology company specializing in the development and production of monoclonal antibodies targeting dendritic cells. Founded in 2005 as a spin-off from the Schering-Plough Laboratory for Immunological Research, the company leverages a proprietary hybridoma platform to create highly specific tools for immunology research and diagnostic applications. Their portfolio includes a wide range of antibodies against human and murine dendritic cell subsets, which are used globally by academic and industrial researchers to study immune responses in cancer, allergy, and infectious diseases. The company's expertise lies in identifying unique cell-surface markers and generating antibodies that can be used for cell sorting, flow cytometry, and immunohistochemistry. In 2018, Dendritics was acquired by Eurobio Scientific to strengthen its research and diagnostic reagent offerings. Today, it operates as a key brand within the Eurobio Scientific group, continuing to innovate in the field of antigen-presenting cell biology.